Panaxod

Is the source of superoxide dismutases (SOD), improving a functional state and accelerating recovery at standard therapy of stomach ulcer and duodenum disease. Panaxod stops a pain syndrome quicker, reduces the term of ulcer defects scarring, significantly reduces expressiveness of endoscopic and histologic manifestations of inflammatory reaction in a periulcerous mucous membrane. It is effective also against other diseases of digestive tract, which are followed by an inflammatory syndrome and
immunodeficiency. This is the only medication for today, containing SOD in a stable form. Effect of the medication is proved by clinical tests.

Recommended:

• standard therapy of stomach ulcer and duodenum disease,
• gastritis,
• full elimination of helicobacter infection,
• digestive tract diseases.

Ingredients:

Filler: microcrystalline cellulose (E 460)